Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001470831-26-000736
Filing Date
2026-07-29
Accepted
2026-07-29 16:17:41
Documents
3
Period of Report
2026-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1785356257.html 3  
1 FORM 3 wk-form3_1785356257.xml 3 1769
2 EX-24 bicara-powerofattorneypo.htm EX-24 5135
3 GRAPHIC bicara-powerofattorneypo001.jpg GRAPHIC 304388
  Complete submission text file 0001470831-26-000736.txt   427700
Mailing Address 395 OYSTER POINT BLVD. SUITE 217 SOUTH SAN FRANCISCO CA 94080
Business Address
Bender Jeremy (Reporting) CIK: 0001863107 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42271 | Film No.: 261217791

Mailing Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)